Lamprini Skorda

Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial

Evangelos J. Giamarellos‐Bourboulis, Athanasios Siampanos, Amalia Bolanou et al. · The Lancet Respiratory Medicine · 2024 · 60 citations

Pharmacy, Infectious Diseases, Pharmacology +16

Evaluation of a Four‐drug, Three‐antibiotic, Nonbismuth–containing “Concomitant” Therapy as First‐line <i>Helicobacter pylori</i> Eradication Regimen in Greece

Sotirios D. Georgopoulos, Vasilios Papastergiou, Elias Xirouchakis et al. · Helicobacter · 2012 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +13

Ultrasonographic Prevalence and Factors Predicting Left Ventricular Diastolic Dysfunction in Patients with Liver Cirrhosis: Is There a Correlation between the Grade of Diastolic Dysfunction and the Grade of Liver Disease?

Vasilios Papastergiou, Lamprini Skorda, Phillipos Lisgos et al. · The Scientific World JOURNAL · 2012 · 24 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: Does ethnicity matter?

Vasilios Papastergiou, Dimitrios Dimitroulopoulos, Lamprini Skorda et al. · Journal of Medical Virology · 2012 · 19 citations

Pharmacy, Infectious Diseases, Internal Medicine +17

Hepatitis C virus genotyping in Greece: Unexpected high prevalence of genotype 5a in a Greek island

Stylianos Karatapanis, Panagiota Tsoplou, Vasilios Papastergiou et al. · Journal of Medical Virology · 2011 · 17 citations

Life Sciences, Infectious Diseases, Microbiology +12